Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Pharmacologic transgene control systems for gene therapy.

Wilfried Weber1, Martin Fussenegger

  • 1Institute for Chemical and Bio-Engineering, Swiss Federal Institute of Technology Zurich-ETH Zurich, ETH Hoenggerberg HCI F 115, Wolfgang-Pauli-Strasse 10, CH-8093 Zurich, Switzerland.

The Journal of Gene Medicine
|March 30, 2006
PubMed
Summary

Precise control over gene therapy is crucial for effective treatment. New genetic tools allow fine-tuning transgene expression for tailored and responsive therapeutic outcomes.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

AI-orchestrated design-build-test-learn is the future of mammalian biodesign.

Nature biomedical engineering·2026
Same author

Optical UVA biosensor platform for high-throughput testing of UV blockers.

The Journal of investigative dermatology·2026
Same author

Self-driving medicine: closed-loop therapeutics for autonomous disease control.

Trends in biotechnology·2026
Same author

A synthetic angiotensin II/ACE2-based hormone shunt controlling experimental hypertension.

Nature communications·2026
Same author

Next-generation programmable cell therapies for precision medicine.

Nature reviews. Genetics·2026
Same author

Traceless Regulation of Genetic Circuitry.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2025

Area of Science:

  • Molecular Biology
  • Gene Therapy
  • Synthetic Biology

Background:

  • Pharmacologic control of transgene expression is vital for advancing gene therapy.
  • Current gene therapy requires precise control over therapeutic transgene transcription and translation.
  • This control is needed for dose titration, adaptive dosing, transcriptome integration, and expression termination.

Purpose of the Study:

  • To review advancements in trigger-inducible transgene control systems.
  • To explore the design of synthetic gene networks for gene therapy.
  • To discuss the delivery of these systems for treating human diseases.

Main Methods:

  • Review of recent developments in mammalian transgene control modalities.
  • Analysis of trigger-inducible systems responsive to heterologous molecules or endogenous signals.

Related Experiment Videos

  • Examination of synthetic gene network designs, including digital switches and transcription cascades.

    • Main Results:

    • Significant progress in developing high-precision, trigger-inducible transgene control systems.
    • Assembly of compatible transcription control systems into higher-order circuitries.
    • Design of synthetic gene networks mimicking digital switches, regulatory cascades, and cellular memory.

    Conclusions:

    • Advanced transgene control systems are enabling sophisticated gene therapy strategies.
    • Synthetic gene networks offer precise, adaptable, and programmable gene expression.
    • These developments pave the way for prototype treatments of various human diseases.